{{Rsnum
|rsid=10492418
|Gene=MYO16
|Chromosome=13
|position=108728378
|Orientation=minus
|GMAF=0.3604
|Gene_s=MYO16
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 36.6 | 48.2 | 15.2
| HCB | 3.6 | 26.3 | 70.1
| JPT | 0.9 | 28.6 | 70.5
| YRI | 9.5 | 42.2 | 48.3
| ASW | 10.5 | 35.1 | 54.4
| CHB | 3.6 | 26.3 | 70.1
| CHD | 5.5 | 26.6 | 67.9
| GIH | 21.8 | 50.5 | 27.7
| LWK | 2.7 | 39.1 | 58.2
| MEX | 10.3 | 43.1 | 46.6
| MKK | 5.8 | 41.7 | 52.6
| TSI | 31.4 | 49.0 | 19.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23509613
  |Trait=Presence of antiphospholipid antibodies
  |Title=Genome-wide association study of antiphospholipid antibodies.
  |RiskAllele=
  |Pval=2E-6
  |OR=2.17
  |ORtxt=[NR]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}